SCHEMBL19082353

SCHEMBL19082353

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5cc6c7cc8ccccc8cc7sc6c6sc7ccccc7c56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.36
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
ALOX5 P09917 1/20 0.34
S1PR5 Q9H228 8/20 0.34
S1PR4 O95977 6/20 0.34
PTPRC P08575 1/20 0.33
PTPRF P10586 1/20 0.33
PTPRA P18433 1/20 0.33
PTPRB P23467 1/20 0.33
PTPN6 P29350 1/20 0.33
DUSP3 P51452 1/20 0.33
PTPN12 Q05209 1/20 0.33
GPR84 Q9NQS5 1/20 0.32
MAPT P10636 1/20 0.31
GSTP1 P09211 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945085 0.93 TNKS (0.39) PTPN1ESR1ESR2TNKSTNKS2
SCHEMBL19082153 0.91 PTPN1 (0.38) PTPN1ESR1ESR2TNKSTNKS2
SCHEMBL19082098 0.90 PTPN1 (0.39) PTPN1ESR1ESR2TNKSTNKS2
SCHEMBL17944217 0.88 ALOX5 (0.40) PTPN1TNKSTNKS2ALOX5S1PR5
SCHEMBL17944211 0.88 PTPN1 (0.39) PTPN1TNKSTNKS2ALOX5S1PR5
SCHEMBL19082346 0.86 TNKS (0.36) PTPN1ESR1ESR2TNKSTNKS2
SCHEMBL17945510 0.84 TNKS (0.39) PTPN1ESR1ESR2TNKSTNKS2
SCHEMBL17932070 0.84 PTPN1 (0.40) PTPN1TNKSTNKS2ALOX5S1PR5
SCHEMBL17945515 0.84 TNKS (0.42) PTPN1TNKSTNKS2ALOX5PTPRC
SCHEMBL17932223 0.84 TNKS (0.43) PTPN1TNKSTNKS2ALOX5PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PTPN1 4695/4885ESR1 225/4885ESR2 542/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PTPN1 4695/4885ESR1 225/4885ESR2 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.